A Consequence of Drug Targeting of Aminoacyl‐tRNA Synthetases in Mycobacterium tuberculosis

Author(s):  
Umar Ndagi ◽  
Hezekiel M. Kumalo ◽  
Ndumiso N. Mhlongo
2020 ◽  
Author(s):  
Karolina Michalska ◽  
Robert Jedrzejczak ◽  
Jacek Wower ◽  
Changsoo Chang ◽  
Beatriz Baragaña ◽  
...  

Abstract Tuberculosis, caused by Mycobacterium tuberculosis, responsible for ~1.5 million fatalities in 2018, is the deadliest infectious disease. Global spread of multidrug resistant TB is a public health threat. Aminoacyl-tRNA synthetases are plausible candidates as potential targets because they play pivotal roles in translating the DNA code into protein sequence by attaching specific amino acid to their cognate tRNAs. One of the best characterized synthetases is specific for L-Phe and tRNAPhe. Here we report structures of M. tuberculosis Phe-tRNA synthetase complexed with precursor tRNA and either phenylalanine or a phenylalanine adenylate analog, 5′-O-(N-phenylalanyl)sulfamoyl-adenosine. Crystallographic models for the first time reveal two modes of interaction with tRNA: an initial recognition via the anticodon loop and stem only and productive binding with interaction of the 3’ end of tRNAPhe with the adenylate site. We biochemically characterize the enzyme and provide the highest resolution, most complete view of the Phe-tRNA synthetase/tRNAPhe system to date.


MedChemComm ◽  
2019 ◽  
Vol 10 (12) ◽  
pp. 2161-2169
Author(s):  
Oksana P. Kovalenko ◽  
Galyna P. Volynets ◽  
Mariia Yu. Rybak ◽  
Sergiy A. Starosyla ◽  
Olga I. Gudzera ◽  
...  

A screen of 37 compounds identified four inhibitors that exhibited dual on-target activity against Mycobacterium tuberculosis aminoacyl-tRNA synthetases.


Author(s):  
Natalie Krahn ◽  
Jeffery M. Tharp ◽  
Ana Crnković ◽  
Dieter Söll

Sign in / Sign up

Export Citation Format

Share Document